| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 3.152 | 63.907 | 63.920 | 68.853 |
| Total Income - EUR | - | - | - | - | - | - | 3.152 | 63.976 | 64.037 | 68.893 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.056 | 22.029 | 32.848 | 21.152 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 95 | 41.947 | 31.189 | 47.741 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 64 | 41.308 | 30.549 | 46.895 |
| Employees | - | - | - | - | - | - | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Danielfinmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 3.256 | 48.827 | 76.077 | 69.189 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 3.152 | 13.875 | 19.573 | 58.790 |
| Cash | - | - | - | - | - | - | 105 | 34.951 | 56.504 | 10.399 |
| Shareholders Funds | - | - | - | - | - | - | 105 | 41.413 | 71.836 | 47.187 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.152 | 7.414 | 4.241 | 22.002 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7810 - 7810" | |||||||||
| CAEN Financial Year |
7810
|
|||||||||
Comments - Danielfinmed S.r.l.